Loading the records…
Loading the records…
The DeOndra Dixon INCLUDE Project Act of 2026 authorizes a Down syndrome research program at NIH but does not appropriate specific funds. It passed the Senate by voice vote on August 6, 2026, and now awaits House action. The bill has no direct near-term market impact due to its authorization-only nature and lack of specified funding.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
The bill has no material market implications. It does not create revenue streams for any publicly traded company. Investors should not expect any stock movement based on this legislation.
The bill, S.1838, passed the Senate on August 6, 2026, by voice vote with an amendment in the nature of a substitute. It is now awaiting action in the House. The legislation amends the Public Health Service Act to authorize the Secretary of Health and Human Services, through the NIH Office of the Director, to carry out a program of research, training, and investigation related to Down syndrome, known as the INCLUDE Project. The bill includes findings on Down syndrome prevalence and co-occurring conditions but does not specify an authorized funding amount. As an authorization bill, it sets policy and spending ceilings but does not allocate actual money; separate appropriations legislation would be required to fund the program. The bipartisan sponsorship (9 cosponsors including Republicans and Democrats) and unanimous consent passage in the Senate indicate broad support, but the lack of a House companion bill and the procedural nature of authorization limit immediate market relevance. No specific companies or sectors beyond healthcare research are directly affected, and the bill does not create procurement or contracting opportunities for publicly traded firms. The legislative path forward requires House passage and presidential signature, but even then, funding depends on future appropriations.
Matched on shared policy language across AI analyses, with ticker & timing weight
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →